Gilead
 
Press Releases

The information in these news pages is accurate or current only as of the date of the particular press release or posting. Gilead does not update press releases once they have been made public. Press releases may contain forward-looking statements. Actual results could vary dramatically as a result of known and unknown risks and uncertainties.

June 26, 2009
European CHMP Adopts Positive Opinion for Aztreonam Lysine

June 18, 2009
Gilead Sciences to Present at the Piper Jaffray 4th Annual Europe Conference on Wednesday, June 24

June 2, 2009
Gilead Sciences to Present at Two Upcoming Investor Conferences

May 28, 2009
Gilead Sciences' Marketing Authorisation Application for Regadenoson Validated by European Medicines Agency

May 22, 2009
Gilead Sciences Announces Changes to Cardiovascular R & D Organization Leadership